SLS Venture

Total investments

14

Average round size

15M

Portfolio companies

8

Lead investments

1

Follow on index

0.43

Exits

4

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyDrug DiscoveryHealth CareHealth DiagnosticsHospitalMedical DeviceMedicalLife SciencePharmaceuticalBiopharma

Summary

The company was established in Europe in Sweden. The leading representative office of defined VC is situated in the Stockholm.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Denmark. Among the most popular fund investment industries, there are Pharmaceutical, Hospital. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Light Sciences Oncology, AdvanDx, OxThera.

The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019. The top activity for fund was in 2005. Considering the real fund results, this VC is 1 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this SLS Venture performs on 8 percentage points less the average number of lead investments.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the SLS Venture, startups are often financed by LD Pensions, Novo Holdings, Essex Woodlands Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are LD Pensions, Novo Holdings, Essex Woodlands Healthcare Partners. In the next rounds fund is usually obtained by LD Pensions, Industrifonden, Sunstone Life Science Ventures.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
14
Lead investments
1
Exits
4
Follow on index
0.43
Investments by industry
  • Biotechnology (14)
  • Health Care (11)
  • Hospital (5)
  • Medical Device (5)
  • Pharmaceutical (4)
  • Show 6 more
Investments by region
  • Denmark (5)
  • United States (6)
  • Sweden (2)
  • Germany (1)
Peak activity year
2005

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Group Appearance index
1.00
Avg. company exit year
17

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Nuevolution 10 Oct 2003 Biotechnology, Health Care, Medical Early Stage Venture 15M Capital Region of Denmark, Copenhagen, Denmark

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.